Summary
Summary The aim of this study was to
The aim of this study was to examine the long-term course of cognitive examine the long-term course of cognitive impairment in people with schizophrenia. impairment in people with schizophrenia. Forty-three people with schizophrenia Forty-three people with schizophrenia were followed up over an average of 33 were followed up over an average of 33 years along with a control group of12 years along with a control group of12 matched individuals free from psychosis. matched individuals free from psychosis. Cognitive function was assessed at Cognitive function was assessed at baseline and follow-up. The participants baseline and follow-up. The participants with schizophrenia were found to show with schizophrenia were found to show impairment in verbal and non-verbal impairment in verbal and non-verbal intelligence at baseline compared with intelligence at baseline compared with estimated premorbid scores, this was not estimated premorbid scores, this was not found in the control group. At follow-up found in the control group. At follow-up there was a significant decline in nonthere was a significant decline in nonverbal intelligence over time in verbal intelligence over time in participants with schizophrenia compared participants with schizophrenia compared with controls ( with controls (P P¼0.007).This differential 0.007).This differential change over time was not seen in verbal change over time was not seen in verbal intelligence ( intelligence (P P¼ 0.318).
0.318).
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Cognitive impairment can be found in the Cognitive impairment can be found in the majority of patients with schizophrenia majority of patients with schizophrenia (Kelly (Kelly et al et al, 2000) and is a strong predictor , 2000) and is a strong predictor of eventual social and functional outcome of eventual social and functional outcome (Green, 1996) . (Green, 1996) . The published research
The published research examining the long-term course of impairexamining the long-term course of impairment is inconsistent. Cross-sectional studies ment is inconsistent. Cross-sectional studies have provided evidence both for (Stratta have provided evidence both for (Stratta et et al al, 2004) and against (Hyde , 2004) and against (Hyde et al et al, 1994) , 1994) progressive deterioration but are vulnerable progressive deterioration but are vulnerable to cohort effects producing differences not to cohort effects producing differences not due to within-individual changes. More due to within-individual changes. More recently, well-designed longitudinal studies recently, well-designed longitudinal studies have again produced conflicting results have again produced conflicting results with some supporting the notion of prowith some supporting the notion of progressive decline (Stirling gressive decline (Stirling et al et al, 2003) and , 2003) and others refuting it (Gold others refuting it (Gold et al et al, 1999; Hoff , 1999; Hoff et al et al, 1999) . Here we report a study exam-, 1999) . Here we report a study examining the course of schizophrenic cognitive ining the course of schizophrenic cognitive impairment over a period of, on average, impairment over a period of, on average, 33 years. 33 years. . For each participant with schizophrenia three each participant with schizophrenia three potential controls matched for year of testpotential controls matched for year of testing, gender and age were identified from ing, gender and age were identified from hospital psychology records. The current hospital psychology records. The current address of only 16 potential controls could address of only 16 potential controls could be identified, two potential controls had debe identified, two potential controls had developed a psychotic disorder during the inveloped a psychotic disorder during the intervening period and were thus excluded tervening period and were thus excluded and two declined to take part in the study, and two declined to take part in the study, leaving 12 participating individuals (2 men leaving 12 participating individuals (2 men and 10 women). The diagnoses in the and 10 women). The diagnoses in the control group were personality disorder control group were personality disorder ( (n n¼5), admitted after overdose ( 5), admitted after overdose (n n¼4), dis-4), dissociative motor disorder ( sociative motor disorder (n n¼1) and moder-1) and moderate depressive episode ( ate depressive episode (n n¼2); the group's 2); the group's mean age was 55.8 years (s.d. mean age was 55.8 years (s.d.¼7.9), the 7.9), the mean number of years of education was mean number of years of education was 10.7 (s.d. 10.7 (s.d.¼1) and the mean follow-up inter-1) and the mean follow-up interval was 30.3 years (s.d. val was 30.3 years (s.d.¼5.4). Baseline neu-5.4). Baseline neuropsychological testing was performed by ropsychological testing was performed by members of the clinical psychology departmembers of the clinical psychology department: for many years this was under the ment: for many years this was under the direct supervision of the psychologist (John direct supervision of the psychologist (John Raven) who designed the tests. At followRaven) who designed the tests. At followup, testing was performed by a trained psyup, testing was performed by a trained psychiatrist and testing was not time-limited. chiatrist and testing was not time-limited. Raven's Standard Progressive Matrices Raven's Standard Progressive Matrices (RSPM; Raven, 1958 (RSPM; Raven, 1958a a) test was adminis-) test was administered at baseline and follow-up. This test tered at baseline and follow-up. This test measures non-verbal abstract reasoning measures non-verbal abstract reasoning and visuospatial problem-solving abilities; and visuospatial problem-solving abilities; it is a valid measure of general and nonit is a valid measure of general and nonverbal intelligence (Lezak, 1995) . The Mill verbal intelligence (Lezak, 1995) . The Mill Hill Vocabulary Scale (MHVS; Raven, Hill Vocabulary Scale (MHVS; Raven, 1958 Raven, 1958b was administered at baseline and ) was administered at baseline and follow-up; this has been used in studies of follow-up; this has been used in studies of people with schizophrenia and provides a people with schizophrenia and provides a valid and reliable measure of verbal intellivalid and reliable measure of verbal intelligence (Lezak, 1995) . At follow-up the Nagence (Lezak, 1995) . At follow-up the National Adult Reading Test (Nelson, 1982) tional Adult Reading Test (Nelson, 1982) was administered as an estimate of premorwas administered as an estimate of premorbid ability, and depressive symptoms were bid ability, and depressive symptoms were rated using the Zung Depression Rating rated using the Zung Depression Rating Scale (ZDRS; Zung, 1965). Independent Scale (ZDRS; Zung, 1965). Independent t t--test analysis was used to compare the test analysis was used to compare the groups on potential confounding variables groups on potential confounding variables and Fisher's exact test was used to test for and Fisher's exact test was used to test for differences in gender ratio. Repeateddifferences in gender ratio. Repeatedmeasure analyses of covariance (ANCOVAs) measure analyses of covariance (ANCOVAs) were performed on cognitive test scores were performed on cognitive test scores (patients (patients v.
METHOD METHOD
v. controls) from baseline and controls) from baseline and follow-up assessments with test-retest follow-up assessments with test-retest interval and ZDRS scores as covariates. interval and ZDRS scores as covariates. Post hoc Post hoc two-tailed two-tailed paired paired t t-tests were -tests were used to assess intraused to assess intra-individual changes in individual changes in cognitive test scores. cognitive test scores.
RESULTS RESULTS
There was no significant difference between There was no significant difference between the control and schizophrenia groups on the control and schizophrenia groups on general characteristics. At follow-up testing general characteristics. At follow-up testing everyone in the schizophrenia group was everyone in the schizophrenia group was receiving antipsychotic medication (typical receiving antipsychotic medication (typical antipsychotics, antipsychotics, n n¼27; atypical antipsycho-27; atypical antipsychotics, tics, n n¼16; 36 were living in the community 16; 36 were living in the community and 7 were long-stay in-patients. None of and 7 were long-stay in-patients. None of the control group was receiving psychotrothe control group was receiving psychotropic medication; all were resident in the pic medication; all were resident in the community. In the schizophrenia group community. In the schizophrenia group there was a highly significant difference bethere was a highly significant difference between estimated premorbid and baseline tween estimated premorbid and baseline RSPM ( RSPM (P P¼0.0004, 0. Repeated-measure ANCOVAs of cogniRepeated-measure ANCOVAs of cognitive test scores at baseline and follow-up tive test scores at baseline and follow-up with test-retest interval and Zung depreswith test-retest interval and Zung depression scores as covariates showed a highly sion scores as covariates showed a highly significant group significant group6 6time interaction in time interaction in RSPM performance over time in participants RSPM performance over time in participants 5 5 6 5 5 6 Fig. 1 (full details follow-up are shown in Fig. 1 (full details of all results available on request). of all results available on request).
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DISCUSSION DISCUSSION
This study offers a view of the long-term This study offers a view of the long-term course of schizophrenic cognitive impaircourse of schizophrenic cognitive impairment over an average of 33 years, some ment over an average of 33 years, some 23 years longer than any recent studies. De-23 years longer than any recent studies. Despite weaknesses inherent in its opportunspite weaknesses inherent in its opportunistic design and difficulties in recruiting istic design and difficulties in recruiting controls, we believe it offers interesting controls, we believe it offers interesting results. Participants with schizophrenia results. Participants with schizophrenia showed broad-based cognitive impairment showed broad-based cognitive impairment early in their illness, as demonstrated by early in their illness, as demonstrated by the significant difference between estimated the significant difference between estimated premorbid scores and actual first-test scores premorbid scores and actual first-test scores on both the MHVS and RSPM. This differon both the MHVS and RSPM. This difference was not seen in the control groups. ence was not seen in the control groups. Subsequently there was no further signifiSubsequently there was no further significant decline in verbal intelligence as meacant decline in verbal intelligence as measured by MHVS in the schizophrenia sured by MHVS in the schizophrenia group even over an extended follow-up pergroup even over an extended follow-up period, and even though this group arguably iod, and even though this group arguably might have been particularly severely afmight have been particularly severely affected given their continued contact with fected given their continued contact with services and need for antipsychotic mediservices and need for antipsychotic medication. cation.
In contrast, there was a significant deIn contrast, there was a significant decline in RSPM scores over time in the cline in RSPM scores over time in the schizophrenia group compared with the schizophrenia group compared with the control group. This could represent a control group. This could represent a genuine decline, but a number of alternative genuine decline, but a number of alternative explanations require consideration. Condiexplanations require consideration. Conditions likely to cause cognitive impairment tions likely to cause cognitive impairment were specifically excluded in the recruitwere specifically excluded in the recruitment process; it is nevertheless possible ment process; it is nevertheless possible that some participants had developed a that some participants had developed a dementia such as Alzheimer's disease. dementia such as Alzheimer's disease. However, the prevalence of Alzheimer's However, the prevalence of Alzheimer's disease in the normal population at this disease in the normal population at this age (mean of the study group was age 61 age (mean of the study group was age 61 years) is low and people with schizophrenia years) is low and people with schizophrenia do not appear to have a higher incidence of do not appear to have a higher incidence of dementia (Purohit dementia (Purohit et al et al, 1998) . Adverse , 1998). Adverse medication effects might impair cognition; medication effects might impair cognition; however, there is variability in the reported however, there is variability in the reported effects of antipsychotic drugs on cognition effects of antipsychotic drugs on cognition (Sharma, 1999) . Could the observed decline (Sharma, 1999) . Could the observed decline be due to normal cognitive ageing? Imporbe due to normal cognitive ageing? Importantly, there was no significant decline in tantly, there was no significant decline in RSPM scores over 30 years in our matched RSPM scores over 30 years in our matched control group. Although to our knowledge control group. Although to our knowledge there are no longitudinal norms for RSPM there are no longitudinal norms for RSPM over extended periods, a recent re-analysis over extended periods, a recent re-analysis of sets of RSPM norms collected at differof sets of RSPM norms collected at different times suggests that little, if any, decline ent times suggests that little, if any, decline occurs in the normal population between occurs in the normal population between the ages of 20 and 70 years (Raven, the ages of 20 and 70 years (Raven, 2000) . 2000). Lastly, testing was not time-limited, Lastly, testing was not time-limited, thus minimising the effect of slowed thus minimising the effect of slowed psychomotor speed with ageing. These psychomotor speed with ageing. These arguments support our belief that the dearguments support our belief that the decline in cognitive functions measured by cline in cognitive functions measured by the RSPM in people with schizophrenia the RSPM in people with schizophrenia (but not observed in our control group) is (but not observed in our control group) is probably genuine. This is in direct contraprobably genuine. This is in direct contradistinction to the 5-year longitudinal studistinction to the 5-year longitudinal studies of Gold dies of Gold et al et al (1999 Gold et al et al ( ) (1999 and Hoff and Hoff et al et al (1999) but is in keeping with a more recent (1999) but is in keeping with a more recent 10-year study showing progressive visuos-10-year study showing progressive visuospatial impairment (Stirling patial impairment (Stirling et al et al, 2003) , , 2003), suggesting cognitive decline in schizosuggesting cognitive decline in schizophrenia occurs over a longer period than phrenia occurs over a longer period than 5 years. Our results also suggest that cogni-5 years. Our results also suggest that cognitive decline is not global, that is it does not tive decline is not global, that is it does not resemble a true dementia, but instead afresemble a true dementia, but instead affects specific areas of cognition and may fects specific areas of cognition and may thus reflect ongoing pathological changes thus reflect ongoing pathological changes in certain areas of the brain or brain in certain areas of the brain or brain systems involved in visuospatial problemsystems involved in visuospatial problemsolving and the fluid components of solving and the fluid components of intelligence. intelligence. AUTHOR'S PROOF AUTHOR'S PROOF 
